26 filings
8-K
GLUE
Monte Rosa Therapeutics Inc
16 May 24
Monte Rosa Therapeutics Announces Pricing of $100 Million Underwritten Public Offering
4:06pm
8-K
GLUE
Monte Rosa Therapeutics Inc
9 May 24
Monte Rosa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
7:05am
8-K
GLUE
Monte Rosa Therapeutics Inc
2 May 24
Departure of Directors or Certain Officers
4:03pm
8-K
GLUE
Monte Rosa Therapeutics Inc
14 Mar 24
Monte Rosa Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
7:05am
8-K
GLUE
Monte Rosa Therapeutics Inc
8 Jan 24
Monte Rosa Therapeutics Provides Corporate Update and Key Anticipated Milestones for 2024
7:47am
8-K
bjjc g99v
9 Nov 23
Monte Rosa Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update
7:27am
8-K
zznu87qdg52pyh6
26 Oct 23
Monte Rosa Therapeutics Announces $25 Million Registered Direct Offering, Priced At- the-Market Under Nasdaq Rules
5:01pm
8-K
napg yy96ahmhyi
17 Oct 23
Monte Rosa to receive an upfront payment of $50 million and potential future payments exceeding $2 billion
7:55am
8-K
viut zdsr7wtn3ckio13
10 Aug 23
Monte Rosa Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update
7:19am
8-K
agi05f siqlyj6hg6
26 Jul 23
Departure of Directors or Certain Officers
7:53am
8-K
x3olw25d8 kqvli
14 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:03pm
8-K
zxum xyrk8mou2c28ot
11 May 23
Monte Rosa Therapeutics Announces First Quarter 2023 Financial Results and Provides Corporate Update
7:34am
8-K
um0tz7b5loi4y7t83l
23 Mar 23
Departure of Directors or Certain Officers
7:33am
8-K
xtx2pb9u1xl422omlnlh
16 Mar 23
Monte Rosa Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
7:34am
8-K
r1xfkbjha9kd5dia1sm
9 Jan 23
From Serendipity to Rational Design Taking Molecular Glue Degraders to New Heights | January 2023
7:33am
8-K
h4uoe00
10 Nov 22
Monte Rosa Therapeutics Reports Third Quarter 2022 Financial Results and Business Updates
7:36am
8-K
etr82m bxiwzy
24 Oct 22
Regulation FD Disclosure
9:17am
8-K
4rljxt
11 Aug 22
Monte Rosa Therapeutics Reports Second Quarter 2022 Financial Results and Business Updates
7:35am
8-K
nkoqwvxz31a0gk
15 Jun 22
Submission of Matters to a Vote of Security Holders
5:08pm
8-K
9nroruydkw
11 May 22
Monte Rosa Therapeutics Reports First Quarter 2022 Financial Results and Business Updates
7:38am